SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
苯甲酸
Lv2
1
110 积分
2023-02-13 加入
最近求助
最近应助
互助留言
Interleukin-33 in atopic dermatitis
2小时前
已完结
Deep screening of antibody–antigen affinities
14天前
已完结
Suspendable Hydrogel Nanovials for Massively Parallel Single-Cell Functional Analysis and Sorting
28天前
已完结
Potent in Vitro and In Vivo Efficacy of BYON4413, a Duba-Based Antibody-Drug Conjugate Targeting CD123 in Acute Myeloid Leukemia
1个月前
已完结
First Disclosure of AZD9829, a TOP1i-ADC Targeting CD123: Promising Preclinical Activity in AML Models with Minimal Effect on Healthy Progenitors
1个月前
已完结
First Disclosure of AZD9829, a TOP1i-ADC Targeting CD123: Promising Preclinical Activity in AML Models with Minimal Effect on Healthy Progenitors
1个月前
已完结
Tagraxofusp, a first‐in‐class CD123‐targeted agent: Five‐year postapproval comprehensive review of the literature
1个月前
已完结
Potent in Vitro and In Vivo Efficacy of BYON4413, a Duba-Based Antibody-Drug Conjugate Targeting CD123 in Acute Myeloid Leukemia
1个月前
已完结
Development of a CD123xCD3 Bispecific Antibody (JNJ-63709178) for the Treatment of Acute Myeloid Leukemia (AML)
1个月前
已关闭
Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody–drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study
1个月前
已完结
没有进行任何应助
速度真快,帮大忙了,么么哒
14天前
内容缺失
1个月前
帮大忙了,速度真快,点赞,感谢,么么哒
1个月前
不需要了【积分已退回】
1个月前
doi错误
11个月前
点赞
11个月前
感谢
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论